Volker Knappertz, MD

Noema Pharma
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• SUN-150 - NOE-PMM-201, Results of Phase 2A Study of Cendifensine (NOE-115) for the Treatment of Vasomotor Symptoms in Menopausal Women

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT